nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE6A—eye—Graves' disease	0.0411	0.0602	CbGeAlD
Dipyridamole—PDE6C—eye—Graves' disease	0.039	0.0571	CbGeAlD
Dipyridamole—PDE6A—pituitary gland—Graves' disease	0.0305	0.0447	CbGeAlD
Dipyridamole—PDE6B—eye—Graves' disease	0.0247	0.0362	CbGeAlD
Dipyridamole—PDE6B—connective tissue—Graves' disease	0.0238	0.0349	CbGeAlD
Dipyridamole—PDE6H—eye—Graves' disease	0.023	0.0337	CbGeAlD
Dipyridamole—PDE6G—eye—Graves' disease	0.0221	0.0324	CbGeAlD
Dipyridamole—PRUNE—pituitary gland—Graves' disease	0.0193	0.0283	CbGeAlD
Dipyridamole—PRUNE—adipose tissue—Graves' disease	0.0192	0.0282	CbGeAlD
Dipyridamole—PDE6D—adipose tissue—Graves' disease	0.0186	0.0272	CbGeAlD
Dipyridamole—PDE1C—thyroid gland—Graves' disease	0.0185	0.027	CbGeAlD
Dipyridamole—PRUNE—thyroid gland—Graves' disease	0.0166	0.0244	CbGeAlD
Dipyridamole—PDE6D—thyroid gland—Graves' disease	0.0161	0.0235	CbGeAlD
Dipyridamole—PDE6B—thyroid gland—Graves' disease	0.0158	0.0232	CbGeAlD
Dipyridamole—PDE11A—thyroid gland—Graves' disease	0.0147	0.0215	CbGeAlD
Dipyridamole—PDE3B—connective tissue—Graves' disease	0.0134	0.0196	CbGeAlD
Dipyridamole—PDE7B—adipose tissue—Graves' disease	0.0132	0.0194	CbGeAlD
Dipyridamole—PDE8A—eye—Graves' disease	0.0128	0.0188	CbGeAlD
Dipyridamole—PDE7B—thyroid gland—Graves' disease	0.0115	0.0168	CbGeAlD
Dipyridamole—PDE2A—pituitary gland—Graves' disease	0.0111	0.0162	CbGeAlD
Dipyridamole—PDE2A—adipose tissue—Graves' disease	0.011	0.0162	CbGeAlD
Dipyridamole—PDE10A—adipose tissue—Graves' disease	0.011	0.0162	CbGeAlD
Dipyridamole—PDE1B—adipose tissue—Graves' disease	0.0109	0.016	CbGeAlD
Dipyridamole—PDE8B—adipose tissue—Graves' disease	0.0105	0.0154	CbGeAlD
Dipyridamole—PDE3B—pituitary gland—Graves' disease	0.0103	0.0151	CbGeAlD
Dipyridamole—PDE3B—adipose tissue—Graves' disease	0.0103	0.0151	CbGeAlD
Dipyridamole—ADA—connective tissue—Graves' disease	0.0102	0.0149	CbGeAlD
Dipyridamole—PDE2A—thyroid gland—Graves' disease	0.00956	0.014	CbGeAlD
Dipyridamole—PDE10A—thyroid gland—Graves' disease	0.00956	0.014	CbGeAlD
Dipyridamole—PDE8A—pituitary gland—Graves' disease	0.00952	0.0139	CbGeAlD
Dipyridamole—PDE8A—adipose tissue—Graves' disease	0.00948	0.0139	CbGeAlD
Dipyridamole—PDE1B—thyroid gland—Graves' disease	0.00947	0.0139	CbGeAlD
Dipyridamole—PDE1A—adipose tissue—Graves' disease	0.00917	0.0134	CbGeAlD
Dipyridamole—PDE8B—thyroid gland—Graves' disease	0.00912	0.0134	CbGeAlD
Dipyridamole—PDE5A—eye—Graves' disease	0.00874	0.0128	CbGeAlD
Dipyridamole—Hepatitis—Methimazole—Graves' disease	0.00872	0.0426	CcSEcCtD
Dipyridamole—PDE5A—connective tissue—Graves' disease	0.00842	0.0123	CbGeAlD
Dipyridamole—PDE8A—thyroid gland—Graves' disease	0.0082	0.012	CbGeAlD
Dipyridamole—PDE1A—thyroid gland—Graves' disease	0.00794	0.0116	CbGeAlD
Dipyridamole—ADA—adipose tissue—Graves' disease	0.0078	0.0114	CbGeAlD
Dipyridamole—Alopecia—Methimazole—Graves' disease	0.00771	0.0376	CcSEcCtD
Dipyridamole—PDE4A—adipose tissue—Graves' disease	0.0076	0.0111	CbGeAlD
Dipyridamole—Haemoglobin—Propylthiouracil—Graves' disease	0.00745	0.0364	CcSEcCtD
Dipyridamole—Hepatitis—Propylthiouracil—Graves' disease	0.00742	0.0362	CcSEcCtD
Dipyridamole—Haemorrhage—Propylthiouracil—Graves' disease	0.00742	0.0362	CcSEcCtD
Dipyridamole—SLC29A1—connective tissue—Graves' disease	0.00707	0.0104	CbGeAlD
Dipyridamole—Vertigo—Methimazole—Graves' disease	0.00682	0.0333	CcSEcCtD
Dipyridamole—ADA—thyroid gland—Graves' disease	0.00675	0.00989	CbGeAlD
Dipyridamole—PDE4A—thyroid gland—Graves' disease	0.00658	0.00964	CbGeAlD
Dipyridamole—Alopecia—Propylthiouracil—Graves' disease	0.00655	0.032	CcSEcCtD
Dipyridamole—Myalgia—Methimazole—Graves' disease	0.00646	0.0316	CcSEcCtD
Dipyridamole—Arthralgia—Methimazole—Graves' disease	0.00646	0.0316	CcSEcCtD
Dipyridamole—PDE5A—adipose tissue—Graves' disease	0.00646	0.00947	CbGeAlD
Dipyridamole—Dysgeusia—Propylthiouracil—Graves' disease	0.00632	0.0309	CcSEcCtD
Dipyridamole—PDE3A—adipose tissue—Graves' disease	0.00629	0.00921	CbGeAlD
Dipyridamole—Oedema—Methimazole—Graves' disease	0.0062	0.0303	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methimazole—Graves' disease	0.00607	0.0296	CcSEcCtD
Dipyridamole—ABCC5—pituitary gland—Graves' disease	0.00593	0.00869	CbGeAlD
Dipyridamole—ABCC5—adipose tissue—Graves' disease	0.00591	0.00866	CbGeAlD
Dipyridamole—Vertigo—Propylthiouracil—Graves' disease	0.0058	0.0283	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00564	0.0276	CcSEcCtD
Dipyridamole—PDE5A—thyroid gland—Graves' disease	0.00559	0.00819	CbGeAlD
Dipyridamole—Paraesthesia—Methimazole—Graves' disease	0.00556	0.0272	CcSEcCtD
Dipyridamole—Somnolence—Methimazole—Graves' disease	0.00551	0.0269	CcSEcCtD
Dipyridamole—Arthralgia—Propylthiouracil—Graves' disease	0.0055	0.0268	CcSEcCtD
Dipyridamole—Myalgia—Propylthiouracil—Graves' disease	0.0055	0.0268	CcSEcCtD
Dipyridamole—Dyspepsia—Methimazole—Graves' disease	0.00545	0.0266	CcSEcCtD
Dipyridamole—SLC29A1—pituitary gland—Graves' disease	0.00545	0.00798	CbGeAlD
Dipyridamole—PDE3A—thyroid gland—Graves' disease	0.00544	0.00797	CbGeAlD
Dipyridamole—SLC29A1—adipose tissue—Graves' disease	0.00543	0.00795	CbGeAlD
Dipyridamole—Oedema—Propylthiouracil—Graves' disease	0.00527	0.0257	CcSEcCtD
Dipyridamole—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00516	0.0252	CcSEcCtD
Dipyridamole—ABCC5—thyroid gland—Graves' disease	0.00512	0.00749	CbGeAlD
Dipyridamole—Urticaria—Methimazole—Graves' disease	0.00492	0.024	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0048	0.0234	CcSEcCtD
Dipyridamole—Paraesthesia—Propylthiouracil—Graves' disease	0.00473	0.0231	CcSEcCtD
Dipyridamole—SLC29A1—thyroid gland—Graves' disease	0.0047	0.00688	CbGeAlD
Dipyridamole—Somnolence—Propylthiouracil—Graves' disease	0.00468	0.0229	CcSEcCtD
Dipyridamole—Dyspepsia—Propylthiouracil—Graves' disease	0.00464	0.0226	CcSEcCtD
Dipyridamole—Pruritus—Methimazole—Graves' disease	0.00438	0.0214	CcSEcCtD
Dipyridamole—Urticaria—Propylthiouracil—Graves' disease	0.00419	0.0204	CcSEcCtD
Dipyridamole—ABCC4—adipose tissue—Graves' disease	0.0041	0.006	CbGeAlD
Dipyridamole—Vomiting—Methimazole—Graves' disease	0.00394	0.0192	CcSEcCtD
Dipyridamole—Rash—Methimazole—Graves' disease	0.00391	0.0191	CcSEcCtD
Dipyridamole—Dermatitis—Methimazole—Graves' disease	0.0039	0.0191	CcSEcCtD
Dipyridamole—Headache—Methimazole—Graves' disease	0.00388	0.019	CcSEcCtD
Dipyridamole—Pruritus—Propylthiouracil—Graves' disease	0.00373	0.0182	CcSEcCtD
Dipyridamole—Nausea—Methimazole—Graves' disease	0.00368	0.018	CcSEcCtD
Dipyridamole—ABCC4—thyroid gland—Graves' disease	0.00355	0.00519	CbGeAlD
Dipyridamole—Vomiting—Propylthiouracil—Graves' disease	0.00335	0.0164	CcSEcCtD
Dipyridamole—Rash—Propylthiouracil—Graves' disease	0.00332	0.0162	CcSEcCtD
Dipyridamole—Dermatitis—Propylthiouracil—Graves' disease	0.00332	0.0162	CcSEcCtD
Dipyridamole—Headache—Propylthiouracil—Graves' disease	0.0033	0.0161	CcSEcCtD
Dipyridamole—Nausea—Propylthiouracil—Graves' disease	0.00313	0.0153	CcSEcCtD
Dipyridamole—PDE3A—G alpha (s) signalling events—TSHR—Graves' disease	0.00157	0.0139	CbGpPWpGaD
Dipyridamole—PDE1C—DAP12 interactions—HLA-E—Graves' disease	0.00154	0.0137	CbGpPWpGaD
Dipyridamole—PDE1A—G alpha (s) signalling events—TSHR—Graves' disease	0.00147	0.0131	CbGpPWpGaD
Dipyridamole—ADA—p73 transcription factor network—FAS—Graves' disease	0.00144	0.0128	CbGpPWpGaD
Dipyridamole—ABCB1—pituitary gland—Graves' disease	0.00143	0.0021	CbGeAlD
Dipyridamole—ABCB1—adipose tissue—Graves' disease	0.00143	0.00209	CbGeAlD
Dipyridamole—PDE1B—G alpha (s) signalling events—TSHR—Graves' disease	0.00135	0.012	CbGpPWpGaD
Dipyridamole—ABCB1—thyroid gland—Graves' disease	0.00123	0.00181	CbGeAlD
Dipyridamole—PDE1C—DAP12 interactions—HLA-B—Graves' disease	0.0011	0.00975	CbGpPWpGaD
Dipyridamole—ABCC5—Carbohydrate metabolism—B3GNT2—Graves' disease	0.000987	0.00877	CbGpPWpGaD
Dipyridamole—SLC29A1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000925	0.00823	CbGpPWpGaD
Dipyridamole—ADA—C-MYB transcription factor network—CD4—Graves' disease	0.000872	0.00775	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 signaling—HLA-E—Graves' disease	0.000872	0.00775	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 interactions—HLA-E—Graves' disease	0.00082	0.00729	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—B3GNT2—Graves' disease	0.000803	0.00714	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—B3GNT2—Graves' disease	0.000803	0.00714	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 signaling—HLA-E—Graves' disease	0.000797	0.00709	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—IFIH1—Graves' disease	0.00076	0.00676	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 interactions—HLA-E—Graves' disease	0.00075	0.00667	CbGpPWpGaD
Dipyridamole—PDE3B—Leptin signaling pathway—IL1B—Graves' disease	0.000748	0.00665	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—TSHR—Graves' disease	0.000739	0.00657	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—TSHR—Graves' disease	0.000739	0.00657	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—TSHR—Graves' disease	0.00072	0.0064	CbGpPWpGaD
Dipyridamole—ADA—Circadian rythm related genes—FAS—Graves' disease	0.000685	0.00609	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—TSHR—Graves' disease	0.000671	0.00596	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—TSHR—Graves' disease	0.000671	0.00596	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—TSHR—Graves' disease	0.000658	0.00585	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—TSHR—Graves' disease	0.000654	0.00581	CbGpPWpGaD
Dipyridamole—ABCC5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000613	0.00545	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—TSHR—Graves' disease	0.000612	0.00544	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—TSHR—Graves' disease	0.000612	0.00544	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—HLA-E—Graves' disease	0.000598	0.00532	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—TSHR—Graves' disease	0.000598	0.00532	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 interactions—HLA-B—Graves' disease	0.000584	0.00519	CbGpPWpGaD
Dipyridamole—PDE2A—Hemostasis—IL2RA—Graves' disease	0.000563	0.005	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—TSHR—Graves' disease	0.000556	0.00494	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—TSHR—Graves' disease	0.000556	0.00494	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—TSHR—Graves' disease	0.000546	0.00485	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 interactions—HLA-B—Graves' disease	0.000534	0.00475	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—B3GNT2—Graves' disease	0.000525	0.00466	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—B3GNT2—Graves' disease	0.000518	0.0046	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—TSHR—Graves' disease	0.000515	0.00458	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—TSHR—Graves' disease	0.000495	0.0044	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—IL2RA—Graves' disease	0.000478	0.00425	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—CXCL10—Graves' disease	0.000477	0.00424	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—CXCL10—Graves' disease	0.000477	0.00424	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TSHR—Graves' disease	0.000466	0.00414	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TSHR—Graves' disease	0.000466	0.00414	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000465	0.00414	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IFIH1—Graves' disease	0.000443	0.00394	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—CXCL10—Graves' disease	0.000434	0.00385	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—CXCL10—Graves' disease	0.000434	0.00385	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.00043	0.00382	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—IL2RA—Graves' disease	0.000426	0.00379	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—IL2RA—Graves' disease	0.000426	0.00379	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—HLA-B—Graves' disease	0.000426	0.00379	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—CXCL10—Graves' disease	0.000425	0.00378	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—GC—Graves' disease	0.000425	0.00378	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000425	0.00378	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—CXCL10—Graves' disease	0.000422	0.00376	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—CD40—Graves' disease	0.00042	0.00373	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000414	0.00368	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IFIH1—Graves' disease	0.000405	0.0036	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TSHR—Graves' disease	0.000396	0.00352	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TSHR—Graves' disease	0.000396	0.00352	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—CXCL10—Graves' disease	0.000396	0.00352	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—CXCL10—Graves' disease	0.000396	0.00352	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—CXCL10—Graves' disease	0.000386	0.00344	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TSHR—Graves' disease	0.000386	0.00343	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IFIH1—Graves' disease	0.00037	0.00329	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—IL2RA—Graves' disease	0.000365	0.00324	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—IL2RA—Graves' disease	0.000365	0.00324	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—CXCL10—Graves' disease	0.000359	0.00319	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—CXCL10—Graves' disease	0.000359	0.00319	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—IL2RA—Graves' disease	0.000356	0.00316	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TSHR—Graves' disease	0.000353	0.00314	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—TSHR—Graves' disease	0.000353	0.00314	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—CXCL10—Graves' disease	0.000353	0.00313	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-E—Graves' disease	0.000348	0.0031	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000341	0.00303	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD40—Graves' disease	0.00034	0.00303	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CTLA4—Graves' disease	0.000336	0.00298	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—CXCL10—Graves' disease	0.000333	0.00296	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—IL2RA—Graves' disease	0.000331	0.00295	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—IL2RA—Graves' disease	0.000331	0.00295	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—TSHR—Graves' disease	0.000331	0.00294	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TSHR—Graves' disease	0.000328	0.00292	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TSHR—Graves' disease	0.000328	0.00292	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—IL2RA—Graves' disease	0.000325	0.00289	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—HLA-A—Graves' disease	0.000325	0.00289	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—HLA-A—Graves' disease	0.000325	0.00289	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—IL2RA—Graves' disease	0.000323	0.00287	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—B3GNT2—Graves' disease	0.000322	0.00286	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—TSHR—Graves' disease	0.000322	0.00286	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—TSHR—Graves' disease	0.000321	0.00285	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—CXCL10—Graves' disease	0.00032	0.00285	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HLA-E—Graves' disease	0.000319	0.00283	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000318	0.00282	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GC—Graves' disease	0.000309	0.00275	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000306	0.00272	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TSHR—Graves' disease	0.000304	0.00271	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—IL2RA—Graves' disease	0.000302	0.00269	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—TSHR—Graves' disease	0.000302	0.00269	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—IL2RA—Graves' disease	0.000302	0.00269	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—CXCL10—Graves' disease	0.000301	0.00268	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—CXCL10—Graves' disease	0.000301	0.00268	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TSHR—Graves' disease	0.0003	0.00267	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—TSHR—Graves' disease	0.0003	0.00267	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000299	0.00266	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL2RA—Graves' disease	0.000295	0.00263	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TSHR—Graves' disease	0.000293	0.0026	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—TSHR—Graves' disease	0.000292	0.0026	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HLA-E—Graves' disease	0.000291	0.00259	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000289	0.00257	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000287	0.00255	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000284	0.00252	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—B3GNT2—Graves' disease	0.00028	0.00248	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—B3GNT2—Graves' disease	0.00028	0.00248	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—TSHR—Graves' disease	0.000277	0.00246	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-DQB1—Graves' disease	0.000276	0.00246	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—IL2RA—Graves' disease	0.000276	0.00245	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL2RA—Graves' disease	0.000275	0.00244	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—TSHR—Graves' disease	0.000275	0.00244	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL2RA—Graves' disease	0.000275	0.00244	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—IL2RA—Graves' disease	0.000269	0.0024	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000259	0.0023	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD8A—Graves' disease	0.000258	0.00229	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CXCL10—Graves' disease	0.000256	0.00228	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CXCL10—Graves' disease	0.000256	0.00228	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—B3GNT2—Graves' disease	0.000256	0.00227	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL2RA—Graves' disease	0.000255	0.00226	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—CD4—Graves' disease	0.000254	0.00226	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—IL2RA—Graves' disease	0.000251	0.00223	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—TSHR—Graves' disease	0.000251	0.00223	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CXCL10—Graves' disease	0.00025	0.00222	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-B—Graves' disease	0.000248	0.00221	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL2RA—Graves' disease	0.000245	0.00218	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—IL2RA—Graves' disease	0.000236	0.0021	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFIH1—Graves' disease	0.000236	0.0021	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—B3GNT2—Graves' disease	0.000234	0.00208	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL2RA—Graves' disease	0.000233	0.00207	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL2RA—Graves' disease	0.00023	0.00205	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL2RA—Graves' disease	0.00023	0.00205	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-A—Graves' disease	0.00023	0.00204	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CXCL10—Graves' disease	0.000228	0.00203	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CXCL10—Graves' disease	0.000228	0.00203	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HLA-B—Graves' disease	0.000227	0.00202	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—IL2RA—Graves' disease	0.000216	0.00192	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFIH1—Graves' disease	0.000216	0.00192	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CXCL10—Graves' disease	0.000214	0.0019	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—HLA-A—Graves' disease	0.000212	0.00189	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CXCL10—Graves' disease	0.000212	0.00189	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CXCL10—Graves' disease	0.000212	0.00189	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HLA-DRB1—Graves' disease	0.00021	0.00187	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—CD4—Graves' disease	0.000209	0.00186	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—CD4—Graves' disease	0.000209	0.00186	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—HLA-A—Graves' disease	0.000209	0.00186	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CXCL10—Graves' disease	0.000208	0.00185	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HLA-B—Graves' disease	0.000208	0.00185	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CXCL10—Graves' disease	0.000207	0.00184	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—ICAM1—Graves' disease	0.000202	0.00179	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CXCL10—Graves' disease	0.000197	0.00175	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL2RA—Graves' disease	0.000196	0.00174	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL2RA—Graves' disease	0.000196	0.00174	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000195	0.00174	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CXCL10—Graves' disease	0.000194	0.00173	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CXCL10—Graves' disease	0.000194	0.00172	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL2RA—Graves' disease	0.000191	0.0017	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TSHR—Graves' disease	0.000189	0.00168	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000189	0.00168	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CXCL10—Graves' disease	0.000189	0.00168	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CXCL10—Graves' disease	0.000189	0.00168	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-E—Graves' disease	0.000186	0.00165	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD40—Graves' disease	0.000181	0.00161	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CTLA4—Graves' disease	0.000179	0.00159	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000179	0.00159	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CXCL10—Graves' disease	0.000177	0.00158	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TSHR—Graves' disease	0.000177	0.00158	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL2RA—Graves' disease	0.000174	0.00155	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—IL2RA—Graves' disease	0.000174	0.00155	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TSHR—Graves' disease	0.000172	0.00153	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-E—Graves' disease	0.00017	0.00151	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000169	0.0015	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000168	0.0015	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD40—Graves' disease	0.000166	0.00147	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IL2RA—Graves' disease	0.000164	0.00146	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CTLA4—Graves' disease	0.000163	0.00145	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—IL2RA—Graves' disease	0.000163	0.00145	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCL10—Graves' disease	0.000162	0.00144	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL2RA—Graves' disease	0.000162	0.00144	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL2RA—Graves' disease	0.000162	0.00144	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TSHR—Graves' disease	0.000162	0.00144	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—IL2RA—Graves' disease	0.000159	0.00141	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL2RA—Graves' disease	0.000158	0.00141	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IFNG—Graves' disease	0.000153	0.00136	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL2RA—Graves' disease	0.00015	0.00134	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000149	0.00133	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TSHR—Graves' disease	0.000148	0.00132	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL2RA—Graves' disease	0.000148	0.00132	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL2RA—Graves' disease	0.000148	0.00132	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD4—Graves' disease	0.000148	0.00132	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000148	0.00131	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-DQB1—Graves' disease	0.000147	0.00131	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2RA—Graves' disease	0.000145	0.00129	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2RA—Graves' disease	0.000144	0.00128	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000142	0.00127	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD8A—Graves' disease	0.000137	0.00122	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL1B—Graves' disease	0.000137	0.00122	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—CD4—Graves' disease	0.000137	0.00122	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000137	0.00121	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2RA—Graves' disease	0.000136	0.00121	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CD4—Graves' disease	0.000136	0.0012	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—CD4—Graves' disease	0.000135	0.0012	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-DQB1—Graves' disease	0.000135	0.0012	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-B—Graves' disease	0.000132	0.00118	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD8A—Graves' disease	0.000126	0.00112	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2RA—Graves' disease	0.000124	0.0011	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CD4—Graves' disease	0.000124	0.0011	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2RA—Graves' disease	0.000124	0.0011	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-A—Graves' disease	0.000123	0.00109	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000122	0.00109	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL10—Graves' disease	0.000122	0.00109	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-B—Graves' disease	0.000121	0.00108	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL10—Graves' disease	0.000115	0.00102	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2RA—Graves' disease	0.000113	0.00101	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HLA-A—Graves' disease	0.000113	0.00101	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HLA-A—Graves' disease	0.000113	0.00101	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-A—Graves' disease	0.000112	0.000996	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-DRB1—Graves' disease	0.000112	0.000995	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL10—Graves' disease	0.000111	0.000991	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ICAM1—Graves' disease	0.000107	0.000955	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL10—Graves' disease	0.000105	0.000932	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HLA-A—Graves' disease	0.000103	0.00092	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-DRB1—Graves' disease	0.000102	0.00091	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ICAM1—Graves' disease	9.82e-05	0.000873	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL10—Graves' disease	9.59e-05	0.000852	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2RA—Graves' disease	9.35e-05	0.000832	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2RA—Graves' disease	8.76e-05	0.000779	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2RA—Graves' disease	8.52e-05	0.000757	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GC—Graves' disease	8.49e-05	0.000755	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNG—Graves' disease	8.17e-05	0.000727	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2RA—Graves' disease	8.01e-05	0.000712	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—Graves' disease	7.89e-05	0.000702	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNG—Graves' disease	7.48e-05	0.000665	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2RA—Graves' disease	7.33e-05	0.000651	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—Graves' disease	7.29e-05	0.000648	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—Graves' disease	7.29e-05	0.000648	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—Graves' disease	7.29e-05	0.000648	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—Graves' disease	7.22e-05	0.000642	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—Graves' disease	6.67e-05	0.000593	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—Graves' disease	6.67e-05	0.000593	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—B3GNT2—Graves' disease	6.43e-05	0.000572	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	6.04e-05	0.000537	CbGpPWpGaD
